Anybody used Google Genomics
I'm thinking these are solved problems and I need to talk management off the ledge.
I'm thinking these are solved problems and I need to talk management off the ledge.
-
-
The Nature interview with David Altshuler about the Global Alliance for Genomics and Health explains a bit about the motivation:
What came out of this week’s meeting?
It was a big tent that brought together stakeholders to identify the most pressing problems the alliance would solve. For example, there is a set of file formats currently used that came out of the 1,000 Genomes Project because we needed it. We think the current generation requires not file formats but machine-readable application programmer interfaces (APIs), and this group is developing — together with academics and for-profit companies — an open-source public API for genome sequencing reads and for genetic variants. That’s a very concrete set of things that we think the field needs.
Is this where Google fits in?
It’s important to realize that the Alliance is 151 members, of which Google is one. We think it’s important to have all the best experts at the table.Comment
-
Programmatic access to data in the ENA / GenBank is essential. Will you archive or just wrap that data?
Will you build bespoke pipelines for typical analysis? If so, how will you reach community consensus on the best tool-suites to use?
How about an 'app store' for bioinformatics analysis? I think that 'open performance evaluation' would be key.
I'm thinking of starting a google-genomics-discuss forum would that be better than ad-hock discussion here?
Cheers,Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment